152 related articles for article (PubMed ID: 35767133)
1. Risk of clear-cell adenocarcinoma of the vagina and cervix among US women with potential exposure to diethylstilbestrol in utero.
White MC; Weir HK; Soman AV; Peipins LA; Thompson TD
Cancer Causes Control; 2022 Aug; 33(8):1121-1124. PubMed ID: 35767133
[TBL] [Abstract][Full Text] [Related]
2. Incidence rates and risks of diethylstilbestrol-related clear-cell adenocarcinoma of the vagina and cervix: Update after 40-year follow-up.
Huo D; Anderson D; Palmer JR; Herbst AL
Gynecol Oncol; 2017 Sep; 146(3):566-571. PubMed ID: 28689666
[TBL] [Abstract][Full Text] [Related]
3. Late cervical and vaginal clear cell adenocarcinoma in women exposed in utero to diethylstilbestrol: Evaluation and screening.
Tournaire M; Gondry J; Mauny L; Devouche E; Morice P
J Gynecol Obstet Hum Reprod; 2023 Oct; 52(8):102630. PubMed ID: 37451413
[TBL] [Abstract][Full Text] [Related]
4. Higher incidence of clear cell adenocarcinoma of the cervix and vagina among women born between 1947 and 1971 in the United States.
Smith EK; White MC; Weir HK; Peipins LA; Thompson TD
Cancer Causes Control; 2012 Jan; 23(1):207-11. PubMed ID: 22015647
[TBL] [Abstract][Full Text] [Related]
5. Cancer risk in women exposed to diethylstilbestrol in utero.
Hatch EE; Palmer JR; Titus-Ernstoff L; Noller KL; Kaufman RH; Mittendorf R; Robboy SJ; Hyer M; Cowan CM; Adam E; Colton T; Hartge P; Hoover RN
JAMA; 1998 Aug; 280(7):630-4. PubMed ID: 9718055
[TBL] [Abstract][Full Text] [Related]
6. Cancer risk in DES daughters.
Verloop J; van Leeuwen FE; Helmerhorst TJ; van Boven HH; Rookus MA
Cancer Causes Control; 2010 Jul; 21(7):999-1007. PubMed ID: 20204493
[TBL] [Abstract][Full Text] [Related]
7. Clear cell adenocarcinoma of the vagina and cervix. An update of the central Netherlands registry showing twin age incidence peaks.
Hanselaar A; van Loosbroek M; Schuurbiers O; Helmerhorst T; Bulten J; Bernhelm J
Cancer; 1997 Jun; 79(11):2229-36. PubMed ID: 9179071
[TBL] [Abstract][Full Text] [Related]
8. Age-incidence and risk of diethylstilbestrol-related clear cell adenocarcinoma of the vagina and cervix.
Herbst AL; Cole P; Colton T; Robboy SJ; Scully RE
Am J Obstet Gynecol; 1977 May; 128(1):43-50. PubMed ID: 851158
[TBL] [Abstract][Full Text] [Related]
9. [Vaginal and cervical cancer due to diethylstilbestrol (DES); end epidemic].
van Dijck JA; Doorduijn Y; Bulten JH; Verloop J; Massuger LF; Kiemeney BA
Ned Tijdschr Geneeskd; 2009; 153():A366. PubMed ID: 19857300
[TBL] [Abstract][Full Text] [Related]
10. Screening for cancers of the cervix and vagina for women exposed to diethylstilbestrol (DES) in utero.
Tournaire M; Devouche E; Lafaye N; Levadou A
J Gynecol Obstet Hum Reprod; 2021 Sep; 50(7):102042. PubMed ID: 33310134
[TBL] [Abstract][Full Text] [Related]
11. Prenatal diethylstilbestrol exposure and high-grade squamous cell neoplasia of the lower genital tract.
Troisi R; Hatch EE; Palmer JR; Titus L; Robboy SJ; Strohsnitter WC; Herbst AL; Adam E; Hyer M; Hoover RN
Am J Obstet Gynecol; 2016 Sep; 215(3):322.e1-8. PubMed ID: 26979629
[TBL] [Abstract][Full Text] [Related]
12. Clear cell adenocarcinoma of the vagina and cervix: incidence, undetected disease, and diethylstilbestrol.
Horwitz RI; Viscoli CM; Merino M; Brennan TA; Flannery JT; Robboy SJ
J Clin Epidemiol; 1988; 41(6):593-7. PubMed ID: 3385459
[TBL] [Abstract][Full Text] [Related]
13. In utero exposure to DES. Evaluation and followup of 199 women.
Fowler WC; Edelman DA
Obstet Gynecol; 1978 Apr; 51(4):459-63. PubMed ID: 662229
[TBL] [Abstract][Full Text] [Related]
14. Factors associated with a lack of pap smear utilization in women exposed in utero to diethylstilbestrol.
Camp EA; Prehn AW; Shen J; Herbst AL; Strohsnitter WC; Hobday CD; Robboy SJ; Adam E
J Womens Health (Larchmt); 2015 Apr; 24(4):308-15. PubMed ID: 25768943
[TBL] [Abstract][Full Text] [Related]
15. Six years' experience with screening of a diethylstilbestrol-exposed population.
Mangan CE; Guintoli RL; Sedlacek TV; Rocereto T; Rubin E; Burtnett M; Mikuta JJ
Am J Obstet Gynecol; 1979 Aug; 134(8):860-5. PubMed ID: 463989
[TBL] [Abstract][Full Text] [Related]
16. Clear cell adenocarcinoma of the vagina and cervix secondary to intrauterine exposure to diethylstilbestrol.
Herbst AL; Anderson D
Semin Surg Oncol; 1990; 6(6):343-6. PubMed ID: 2263810
[TBL] [Abstract][Full Text] [Related]
17. Congenital diethylstilbestrol-associated vaginal/cervical adenosis (DES babies).
Barclay DL
J Ark Med Soc; 1979 May; 75(12):451-2. PubMed ID: 156173
[TBL] [Abstract][Full Text] [Related]
18. DES daughters in France: experts' points of view on the various genital, uterine and obstetric pathologies, and in utero DES exposure.
Clement R; Guilbaud E; Barrios L; Rougé-Maillart C; Jousset N; Rodat O
Med Sci Law; 2014 Oct; 54(4):219-29. PubMed ID: 24534146
[TBL] [Abstract][Full Text] [Related]
19. Prenatal diethylstilbestrol (DES) exposure. Recommendations of the Diethylstilbestrol-Adenosis (DESAD) Project for the identification and management of exposed individuals.
Clin Pediatr (Phila); 1983 Feb; 22(2):139-43. PubMed ID: 6822019
[TBL] [Abstract][Full Text] [Related]
20. Diethylstilbestrol (DES)-induced clear cell adenocarcinoma of the vagina metastasizing to the brain.
Lin LM; Sciubba DM; Gallia GL; Sosnowski J; Weingart JD
Gynecol Oncol; 2007 Apr; 105(1):273-6. PubMed ID: 17292458
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
